サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1463134

食欲抑制剤市場、シェア、規模、動向、産業分析レポート：薬剤クラス別、投与経路別、エンドユーザー別、地域別、セグメント別予測、2024年～2032年

Anorexiants Market Share, Size, Trends, Industry Analysis Report, By Drug Class (Catecholamines, Serotonin); By Route of Administration; By End User; By Region; Segment Forecast, 2024 - 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 118 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.91円
食欲抑制剤市場、シェア、規模、動向、産業分析レポート：薬剤クラス別、投与経路別、エンドユーザー別、地域別、セグメント別予測、2024年～2032年
出版日: 2024年03月24日
発行: Polaris Market Research
ページ情報: 英文 118 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界の食欲抑制剤市場規模は2032年までに14億313万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

世界の食欲抑制剤市場の成長は、ある意味で食欲を制限する体重管理に対する消費者の関心の高まりに大きく起因しています。食欲を抑制する薬剤クラス別が入手可能になったことで、カロリー摂取をコントロールする手段として消費者の関心を集め、より高い需要を生み出しています。これが、製薬会社の生産能力増強の原動力となっています。例えば、ノボ・ホールディングスは2024年2月、減量注射薬ウェゴビーと糖尿病注射薬オゼンピックの供給を促進するため、165億米ドルでキャタレントを買収する戦略を発表しました。

今後肥満に悩む人の数が大幅に増加するため、調査期間中のマーケットプレースでは食欲管理薬に対する大きな需要が見込まれます。World Obesity Federation Report 2023によると、2035年までに世界人口の50％以上にあたる約400万人が肥満になると推定されています。

エネルギー消費量と身体活動に費やされるエネルギーとのギャップが拡大していることが、肥満の増加をもたらす建築要因となっています。ソーシャル・メディアの利用が増えたため、体型を重視したライフスタイルの改善を選択する人が増えたことが、食欲抑制剤などの需要を刺激しています。2023年の調査では、米国の有色人種の若者の体重管理教育において、TikTokとInstagramが大きな影響力を持っていることがわかった。

肥満者の心停止、2型糖尿病、特定のがんなどの慢性疾患の流行は、治療のために医師に相談する消費者の注目を集め、ヘルスケア環境における食欲抑制剤などの肥満治療薬の必要性を促進しています。コロラド大学ボルダー校の2023年の調査によると、肥満は死亡リスクを最低22％から最高91％まで高めるといいます。別の研究によると、肥満の人が食事療法と身体活動で体重を5～10％減らすと、肥満の成人の心血管疾患の発症リスクが低下しました。

肥満の治療と体重管理のための新しい薬物製剤の技術革新に焦点を当てた調査研究の増加は、世界における食欲抑制剤の大きな需要を示すと予想されます。例えば、2023年11月、米国食品医薬品局（FDA）は、慢性体重管理注射薬ゼップバウンド（チルゼパチド）の承認を発表しました。2024年1月には、Eli Lilly社が肥満治療薬Mounjaroを来年インドに導入する計画を発表しました。

食欲抑制剤市場レポートハイライト

カテコールアミン部門は、エネルギー消費を促進する効果的な性能により、今後数年間で最も高い成長が見込まれます。

経口薬セグメントは、服薬の利便性により最大の市場シェアを占めています。

病院セグメントは、肥満患者のための治療を提供する病院の存在により、より大きな収益シェアを経験すると予測されています。

アジア太平洋地域は、肥満の罹患率の増加に起因して、予測期間中に最も速い成長を記録すると予測されています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の食欲抑制剤市場の洞察

  • 食欲抑制剤市場- エンドユーザースナップショット
  • 食欲抑制剤市場力学
    • 促進要因と機会
      • 身体活動の低さ
      • 減量薬の需要増加
    • 抑制要因と課題
      • 規制上のハードルと副作用
  • PESTEL分析
  • 食欲抑制剤市場のエンドユーザーの動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 薬剤クラス別の世界市場

  • 主な調査結果
  • イントロダクション
  • カテコールアミン
  • セロトニン

第6章 投与経路別の世界市場

  • 主な調査結果
  • イントロダクション
  • 経口
  • 皮下

第7章 エンドユーザー別の世界市場

  • 主な調査結果
  • イントロダクション
  • 業務販売
  • 病院
  • クリニック
  • 小売販売
  • オンライン薬局
  • 通信販売薬局

第8章 地域別の世界市場

  • 主な調査結果
  • イントロダクション
    • 食欲抑制剤市場評価、地域別、2019-2032年
  • 食欲抑制剤市場-北米
    • 北米：食欲抑制剤市場、薬剤クラス別、2019年～2032年
    • 北米：食欲抑制剤市場、エンドユーザー別、2019年～2032年
    • 北米：食欲抑制剤市場、投与経路別、2019年～2032年
    • 食欲抑制剤市場-米国
    • 食欲抑制剤市場- カナダ
  • 食欲抑制剤市場- 欧州
    • 欧州：食欲抑制剤市場、薬剤クラス別、2019年～2032年
    • 欧州：食欲抑制剤市場、エンドユーザー別、2019-2032年
    • 欧州：食欲抑制剤市場、投与経路別、2019年～2032年
    • 食欲抑制剤市場- 英国
    • 食欲抑制剤市場- フランス
    • 食欲抑制剤市場- ドイツ
    • 食欲抑制剤市場- イタリア
    • 食欲抑制剤市場- スペイン
    • 食欲抑制剤市場- オランダ
    • 食欲抑制剤市場- ロシア
  • 食欲抑制剤市場- アジア太平洋
    • アジア太平洋地域：食欲抑制剤市場、薬剤クラス別、2019-2032年
    • アジア太平洋地域：食欲抑制剤市場、エンドユーザー別2019年～2032年
    • アジア太平洋地域：食欲抑制剤市場、投与経路別2019-2032年
    • 食欲抑制剤市場- 中国
    • 食欲抑制剤市場- インド
    • 食欲抑制剤市場- マレーシア
    • 食欲抑制剤市場- 日本
    • 食欲抑制剤市場- インドネシア
    • 食欲抑制剤市場- 韓国
  • 食欲抑制剤市場-中東およびアフリカ
    • 中東およびアフリカ：食欲抑制剤市場、薬剤クラス別、2019-2032年
    • 中東およびアフリカ：食欲抑制剤市場、エンドユーザー別2019年～2032年
    • 中東およびアフリカ：食欲抑制剤市場、投与経路別、2019-2032年
    • 食欲抑制剤市場- サウジアラビア
    • 食欲抑制剤市場-UAE
    • 食欲抑制剤市場- イスラエル
    • 食欲抑制剤市場- 南アフリカ
  • 食欲抑制剤市場-ラテンアメリカ
    • ラテンアメリカ：食欲抑制剤市場、薬剤クラス別、2019年～2032年
    • ラテンアメリカ：食欲抑制剤市場、エンドユーザー別、2019-2032年
    • ラテンアメリカ：食欲抑制剤市場、投与経路別、2019年～2032年
    • 食欲抑制剤市場- メキシコ
    • 食欲抑制剤市場- ブラジル
    • 食欲抑制剤市場- アルゼンチン

第9章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • パートナーシップ/コラボレーション/契約/公開

第10章 企業プロファイル

  • AstraZeneca（UK）
  • Aurobindo Pharma（India）
  • Bausch Health Companies Inc.（Canada）
  • Cipla Inc.（US）
  • Currax Pharmaceuticals LLC（US）
  • Eisai Co., Ltd.（Japan）
  • F. Hoffmann-La Roche Ltd.（Switzerland）
  • GlaxoSmithKline plc（UK）
  • Johnson & Johnson Private Limited（US）
  • Lannett（US）
  • Merck & Co., Inc.（US）
  • Mylan N.V.（US）
  • Novartis AG（Switzerland）
図表

List of Tables

  • Table 1 Global Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 2 Global Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 3 Global Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 4 Anorexiants Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 6 North America: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 7 North America: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 8 U.S.: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 9 U.S.: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 10 U.S.: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 11 Canada: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 12 Canada: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 13 Canada: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 14 Europe: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 15 Europe: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 16 Europe: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 17 UK: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 18 UK: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 19 UK: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 20 France: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 21 France: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 22 France: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 23 Germany: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 24 Germany: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 25 Germany: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 26 Italy: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 27 Italy: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 28 Italy: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 29 Spain: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 30 Spain: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 31 Spain: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 32 Netherlands: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 33 Netherlands: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 34 Netherlands: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 35 Russia: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 36 Russia: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 37 Russia: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 41 China: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 42 China: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 43 China: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 44 India: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 45 India: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 46 India: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 47 Malaysia: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 48 Malaysia: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 49 Malaysia: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 50 Japan: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 51 Japan: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 52 Japan: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 53 Indonesia: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 54 Indonesia: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 55 Indonesia: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 56 South Korea: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 57 South Korea: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 58 South Korea: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 65 UAE: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 66 UAE: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 67 UAE: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 68 Israel: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 69 Israel: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 70 Israel: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 71 South Africa: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 72 South Africa: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 73 South Africa: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 74 Latin America: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 75 Latin America: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 76 Latin America: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 77 Mexico: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 78 Mexico: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 79 Mexico: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 80 Brazil: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 81 Brazil: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 82 Brazil: Anorexiants Market, by End User, 2019-2032 (USD Million)
  • Table 83 Argentina: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • Table 84 Argentina: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • Table 85 Argentina: Anorexiants Market, by End User, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Anorexiants Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Route of Admission
  • Figure 7. Global Anorexiants Market, by Route of Admission, 2022 & 2032 (USD Million)
  • Figure 8. Market by Drug Class
  • Figure 9. Global Anorexiants Market, by Drug Class, 2022 & 2032 (USD Million)
  • Figure 10. Market by End User
  • Figure 11. Global Anorexiants Market, by End User, 2022 & 2032 (USD Million)
  • Figure 12. Anorexiants Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Anorexiants Market
目次
Product Code: PM4793

The global anorexiants market size is expected to reach USD 1,403.13 million by 2032, according to a new study by Polaris Market Research. The report "Anorexiants Market Share, Size, Trends, Industry Analysis Report, By Drug Class (Catecholamines, Serotonin); By Route of Administration; By End User; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The growth of the global anorexiants market is highly attributable to the rising consumer interest in weight management, which, in a way, limits appetite. The availability of the class of drugs that suppress appetite is gaining consumers attention as a measure to control calorie intake, creating higher demand. This is driving the pharmaceutical companies to enhance their production capacity. For instance, in February 2024, Novo Holdings unveiled its strategy to acquire Catalent to promote the supply of Wegovy, a weight loss injection, and Ozempic, a diabetic shot, for $16.5 billion.

As the number of people suffering from obesity grows significantly in the future, there will be a huge demand for appetite management drugs in the marketplace during the study period. According to the World Obesity Federation Report 2023, about 4 million people, which is more than 50% of the global population, are estimated to be obese by 2035.

The growing gap between energy consumption and energy spent on physical activities is the building factor leading to the rise in obesity. The increase in the number of people opting for lifestyle modification, with a higher focus on body look due to the growing use of social media, is stimulating the demand for appetite-control medications, such as anorexiants. A 2023 study found that TikTok and Instagram have a significant influence in educating weight management among youth of color in the United States.

The prevalence of chronic diseases, such as cardiac arrest, type 2 diabetes, and certain cancers, among obese people is grabbing the attention of consumers to consult doctors for treatment, facilitating the need for obese medications, including anorexiants, in healthcare settings. According to the University of Colorado Boulder Research in 2023, obesity increases the risk of death from a minimum of 22% to a maximum of 91%. According to another study, losing weight by 5-10% with diet and physical activities among obese people lowered the risk of developing cardiovascular disease among obese adults.

The growing research studies focusing on the innovation of new medication formulations for the treatment of obesity and weight management are anticipated to showcase significant demand for anorexiants in the world. For instance, in November 2023, the U.S. Food and Drug Administration (FDA) announced the approval of a chronic weight management injection, Zepbound (tirzepatide). In January 2024, Eli Lilly announced its plan to introduce the obesity drug Mounjaro in India in the next year.

Anorexiants Market Report Highlights

The catecholamines segment is anticipated to witness the highest growth in the coming years due to its effective performance in boosting energy expenditure.

Oral segment accounted for the largest market share owing to its convenience in taking medication.

The hospitals segment is projected to experience a larger revenue share due to the presence of hospitals offering treatment for obese patients.

Asia Pacific is projected to register the fastest growth during the forecast period, attributable to the increasing incidence of obesity.

The global players include AstraZeneca, Aurobindo Pharma, Bausch Health Companies Inc., Cipla Inc., Currax Pharmaceuticals LLC, & Eisai Co., Ltd.

Polaris Market Research has segmented the anorexiants market report based on drug class, route of administration, end user and region:

Anorexiants, Drug Class Outlook (Revenue - USD Million, 2019 - 2032)

  • Catecholamines
  • Serotonin

Anorexiants, Route of Admission Outlook (Revenue - USD Million, 2019 - 2032)

  • Oral
  • Subcutaneous

Anorexiants, End User Outlook (Revenue - USD Million, 2019 - 2032)

  • Institutional sales
  • Hospitals
  • Clinics
  • Retail sales
  • Online pharmacies
  • Mail Order Pharmacies

Anorexiants, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Anorexiants Market Insights

  • 4.1. Anorexiants Market - End User Snapshot
  • 4.2. Anorexiants Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. The presence of lower physical activity in the population
      • 4.2.1.2. Increase in the demand for weight-loss drugs
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Regulatory hurdles and side effects
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Anorexiants Market End User Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Anorexiants Market, by Drug Class

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  • 5.3. Catecholamines
    • 5.3.1. Global Anorexiants Market, by Catecholamines, by Region, 2019-2032 (USD Million)
  • 5.4. Serotonin
    • 5.4.1. Global Anorexiants Market, by Serotonin, by Region, 2019-2032 (USD Million)

6. Global Anorexiants Market, by Route of Admission

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • 6.3. Oral
    • 6.3.1. Global Anorexiants Market, by Oral, by Region, 2019-2032 (USD Million)
  • 6.4. Subcutaneous
    • 6.4.1. Global Anorexiants Market, by Subcutaneous, by Region, 2019-2032 (USD Million)

7. Global Anorexiants Market, by End User

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Anorexiants Market, by End User, 2019-2032 (USD Million)
  • 7.3. Institutional sales
    • 7.3.1. Global Anorexiants Market, by Institutional sales, By Region, 2019-2032 (USD Million)
  • 7.4. Hospitals
    • 7.4.1. Global Anorexiants Market, by Hospitals, By Region, 2019-2032 (USD Million)
  • 7.5. Clinics
    • 7.5.1. Global Anorexiants Market, by Clinics, By Region, 2019-2032 (USD Million)
  • 7.6. Retail sales
    • 7.6.1. Global Anorexiants Market, by Retail sales, By Region, 2019-2032 (USD Million)
  • 7.7. Online pharmacies
    • 7.7.1. Global Anorexiants Market, by Online pharmacies, By Region, 2019-2032 (USD Million)
  • 7.8. Mail Order Pharmacies
    • 7.8.1. Global Anorexiants Market, by Mail Order Pharmacies, By Region, 2019-2032 (USD Million)

8. Global Anorexiants Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Anorexiants Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Anorexiants Market - North America
    • 8.3.1. North America: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
    • 8.3.2. North America: Anorexiants Market, by End User, 2019-2032 (USD Million)
    • 8.3.3. North America: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.3.4. Anorexiants Market - U.S.
      • 8.3.4.1. U.S.: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.3.5. Anorexiants Market - Canada
      • 8.3.5.1. Canada: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • 8.4. Anorexiants Market - Europe
    • 8.4.1. Europe: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Anorexiants Market, by End User, 2019-2032 (USD Million)
    • 8.4.3. Europe: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.4.4. Anorexiants Market - UK
      • 8.4.4.1. UK: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.4.5. Anorexiants Market - France
      • 8.4.5.1. France: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.4.5.3. France: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.4.6. Anorexiants Market - Germany
      • 8.4.6.1. Germany: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.4.7. Anorexiants Market - Italy
      • 8.4.7.1. Italy: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.4.8. Anorexiants Market - Spain
      • 8.4.8.1. Spain: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.4.9. Anorexiants Market - Netherlands
      • 8.4.9.1. Netherlands: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.4.10. Anorexiants Market - Russia
      • 8.4.10.1. Russia: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • 8.5. Anorexiants Market - Asia Pacific
    • 8.5.1. Asia Pacific: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Anorexiants Market, by End User, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.5.4. Anorexiants Market - China
      • 8.5.4.1. China: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.5.4.3. China: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.5.5. Anorexiants Market - India
      • 8.5.5.1. India: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.5.5.3. India: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.5.6. Anorexiants Market - Malaysia
      • 8.5.6.1. Malaysia: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.5.7. Anorexiants Market - Japan
      • 8.5.7.1. Japan: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.5.8. Anorexiants Market - Indonesia
      • 8.5.8.1. Indonesia: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.5.9. Anorexiants Market - South Korea
      • 8.5.9.1. South Korea: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • 8.6. Anorexiants Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Anorexiants Market, by End User, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.6.4. Anorexiants Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.6.5. Anorexiants Market - UAE
      • 8.6.5.1. UAE: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.6.6. Anorexiants Market - Israel
      • 8.6.6.1. Israel: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.6.7. Anorexiants Market - South Africa
      • 8.6.7.1. South Africa: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
  • 8.7. Anorexiants Market - Latin America
    • 8.7.1. Latin America: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Anorexiants Market, by End User, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.7.4. Anorexiants Market - Mexico
      • 8.7.4.1. Mexico: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.7.5. Anorexiants Market - Brazil
      • 8.7.5.1. Brazil: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
    • 8.7.6. Anorexiants Market - Argentina
      • 8.7.6.1. Argentina: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Anorexiants Market, by End User, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. AstraZeneca (UK)
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Aurobindo Pharma (India)
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Bausch Health Companies Inc. (Canada)
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Cipla Inc. (US)
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Currax Pharmaceuticals LLC (US)
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Eisai Co., Ltd. (Japan)
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. F. Hoffmann-La Roche Ltd. (Switzerland)
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. GlaxoSmithKline plc (UK)
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Johnson & Johnson Private Limited (US)
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Lannett (US)
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Merck & Co., Inc. (US)
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Mylan N.V. (US)
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Novartis AG (Switzerland)
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development